Recognizing the number of cases currently filed against it; and the potential for a significant number more, pharmaceutical giant GlaxoSmtihKline has requested that all Zofran birth defect lawsuits be consolidated into one multi-district litigation, or MDL.
MDLs are generally used as a tool for increasing the efficiency of of legal proceedings when a number of similar lawsuits are filed. When a large number of lawsuits are filed across a range of ...
continue reading...
The U.S. Food and Drug Administration (FDA) has announced it will switch to a new drug safety labeling system that will provide more information to pregnant women and their doctors, the Chicago Tribune report. According to the article, this revision to prescription guidelines will be the first since 1979.
The new drug safety labeling system will replace the current A–X grading scheme and provide ...
continue reading...
A new study published in Pediatric Emergency Care has found a possible connection between the antiemetic drug ondansetron, marketed as Zofran, and the deaths of two children.
The study reports on two cases of fatal cardiac arrest that occurred in children after they were given Zofran. One of the children, a 10-year-old boy with no previous health conditions, was admitted to the emergency room with stomach flu symptoms. After extensive ...
continue reading...Nausea is one of the worst feelings in the world; there is no easier or cleaner way to say it. When patients experiencing nausea have the chance to make it go away, they generally will jump at the chance.
Zofran has been a popular antiemetic (nausea treatment) since its approval in 1991 with sales routinely over $1 billion per year. Produced by drug manufacturer GlaxoSmithKline, it is intended to help with ...
continue reading...
